{{Rsnum
|rsid=1432679
|Gene=EBF1
|Chromosome=5
|position=158817075
|Orientation=plus
|GMAF=0.3898
|Gene_s=EBF1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 17.9 | 46.4 | 35.7
| HCB | 38.0 | 48.2 | 13.9
| JPT | 39.8 | 52.2 | 8.0
| YRI | 74.1 | 23.1 | 2.7
| ASW | 61.4 | 33.3 | 5.3
| CHB | 38.0 | 48.2 | 13.9
| CHD | 42.2 | 45.0 | 12.8
| GIH | 18.8 | 29.7 | 51.5
| LWK | 77.3 | 21.8 | 0.9
| MEX | 34.5 | 48.3 | 17.2
| MKK | 72.4 | 25.0 | 2.6
| TSI | 21.6 | 51.0 | 27.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535733
  |Trait=Breast cancer
  |Title=Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
  |RiskAllele=C
  |Pval=7E-6
  |OR=1.08
  |ORtxt=[1.04-1.11]
  |OA=1
}}
{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=C
  |Pval=2E-14
  |OR=1.07
  |ORtxt=[1.05-1.09]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}